Orbimed Advisors LLC bought $15M of QTTB
director, owner at Q32 Bio Inc.. 1,875,000 shares at an average of $8.00, traded May 28, 2026, filed Jun 1, 2026.
Score components
- +15RoleDirector
- +25Trade size$15.0M at market
- +10Relative to holdingsHoldings up 83%
- +4Price context20% below the 52-week high
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- -5Track recordMedian 6-month excess return -26% over 4 past buys
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000947871-26-000593, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 28, 2026 | POpen-market purchase Common Stockindirect: See footnotes | +1,250,000 | $8.00 | $10M | 3,502,987 | Jun 1, 2026 |
| May 28, 2026 | POpen-market purchase Common Stockindirect: See footnotes | +625,000 | $8.00 | $5.0M | 625,000 | Jun 1, 2026 |
Related signals
Other insiders at Q32 Bio Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | Q32 Bio Inc. | Lee Kalowski CFO and President | $66k 3,972 shares | -3% | |
| 51Moderate | Q32 Bio Inc. | Jodie Pope Morrison CEO | $163k 9,845 shares | -3% | |
| 36Weak | Q32 Bio Inc. | Shelia M. Violette Chief Scientific Officer | $46k 2,798 shares | -2% | |
| 62Notable | Q32 Bio Inc. | Diyong Xu director, owner | $15M 1,875,000 shares | +83% | |
| 42Moderate | Q32 Bio Inc. | Lee Kalowski CFO and President | $18k 3,995 shares | -10% | |
| 46Moderate | Q32 Bio Inc. | Jodie Pope Morrison CEO | $45k 9,896 shares | -10% | |
| 30Weak | Q32 Bio Inc. | Shelia M. Violette Chief Scientific Officer | $13k 2,815 shares | -5% | |
| 40Moderate | Q32 Bio Inc. | Lee Kalowski CFO and President | $31k 9,072 shares | -19% | |
| 47Moderate | Q32 Bio Inc. | Jodie Pope Morrison CEO | $78k 22,506 shares | -19% | |
| 37Weak | Q32 Bio Inc. | Lee Kalowski CFO and President | $7,636 4,240 shares | -8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.